Insights into organoid-based modeling of COVID-19 pathology

Area of Science:

• * Regenerative Medicine
• * Infectious Disease Research
• * Stem Cell Biology

Background:

• * The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019 necessitated urgent research into its biology and pathogenesis.
• * Traditional research models faced limitations in fully recapitulating the complexities of SARS-CoV-2 infection and coronavirus disease 2019 (COVID-19).
• * Organoid technology, a form of mini-organ modeling, has gained prominence for its ability to mimic human organ physiology and pathology.

Purpose of the Study:

• * To review the application of stem cell-derived organoids in studying SARS-CoV-2.
• * To highlight the role of organoid models in understanding COVID-19 disease mechanisms.
• * To provide a perspective on organoid-based drug development for COVID-19 treatment.

Main Methods:

• * Review of existing literature on organoid models for SARS-CoV-2 research.
• * Analysis of studies utilizing stem cells to create organoids mimicking COVID-19.
• * Synthesis of findings related to organoid applications in drug discovery and therapeutic improvement.

Main Results:

• * Organoid models effectively replicate key aspects of SARS-CoV-2 infection and COVID-19 pathology.
• * Regenerative medicine approaches using organoids have shown significant support in controlling COVID-19.
• * Organoid systems facilitate the optimization of drug screening and therapeutic strategies.

Conclusions:

• * Stem cell-derived organoids are valuable tools for advancing the understanding of SARS-CoV-2 and COVID-19.
• * Organoid-based research is crucial for accelerating the development of effective treatments and therapies.
• * The continued application of organoid technology holds promise for future pandemic preparedness and response.